Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Snakebite envenomation is a neglected global health problem, causing substantial mortality, disability, and psychological morbidity, especially in rural tropical and subtropical zones. Antivenin is currently the only specific medicine for envenomation. However, it is restricted by cold storage, snakebite diagnosis, and high price. Snake venom phospholipase A 2 s (svPLA 2 s) are found in all kinds of venomous snake families (e.g., Viperidae, Elapidae, and Colubridae). Along with their catalytic activity, svPLA 2 s elicit a wide variety of pharmacological effects that play a pivotal role in envenomation damage. Hence, neutralization of the svPLA 2 s could weaken or inhibit toxic damage. Here we overviewed the latest knowledge on the distribution, pathophysiological effects, and inhibitors of svPLA 2 s to elucidate the potential for a novel, wide spectrum antivenom drug targeting svPLA 2 s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 SDS-PAGE profile of major venom components in the main clades of venomous snakes (adapted from [20]). (a) Families: Elapidae, subfamilies Elapinae, Laticaudinae, Hydrophiinae, and Colubrinae. (b) Family: Viperidae, and subfamilies: Crotalinae (C) and Viperinae (V). Ovals enclose some bands that are typical of protein families, based on published mass. (?) indicates hypothetical protein family or activity.](https://figures.cochat.ai/paper-figures/75223b9f6ce04521a353772cd4263c61/snake-venom-pla-sub-2-sub-a-promising-target-for-broad-spectrum-antivenom-drug-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Snake venom phospholipase A2 (svPLA2) is one of the most abundant toxin families in snake venom and plays a central role in snakebite envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“It hydrolyzes the phospholipids of the cell membrane at the sn-2 position of the glycerophospholipids, thereby releasing free fatty acids and lysophospholipids [9].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
Six, D. A., & Dennis, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00105-0 · Cited by 1,358 · cited 2×
“InGroup I there are approximately 115–120 residues, 7 disulfide bonds (the unique disulfide linking residues 11 and 77), and G IA has a characteristic surface loop between residues 63 to 67 called elapidic loop [11].”
BackgroundDennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
Mishra, L. C., Singh, B. B., & Dagenais, S. (2000) · PubMed · Cited by 1,173
The phospholipase A2 superfamily and its group numbering system
Schaloske, R. H., & Dennis, E. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.011 · Cited by 936
Snake-bites: appraisal of the global situation.
Chippaux, J. (1998) · Europe PMC (PubMed Central) · Cited by 932
Warrell, D. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61754-2 · Cited by 774
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes
Manjunatha Kini, R. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.002 · Cited by 720 · cited 1×
“The diverse toxic effects are tightly related to the multiple functional sites on the surface of svPLA2s and their different binding receptors [25].”
BackgroundConfronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global Partnership
Gutiérrez, J. M., Theakston, R. D. G., & Warrell, D. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030150 · Cited by 555
Gutiérrez, J. M., & Ownby, C. L. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.005 · Cited by 444 · cited 12×
“These nonimmunoglobulin antitoxins are PLA2 inhibitors (i.e., snake blood phospholipase A2 inhibitors, sbPLIs) and are used to protect the snake from the internal or external envenomation. sbPLIs can be produced by snakes of the Elapidae, Viperidae, Hydrophidae, Colubridae and Boidae families.”
BackgroundInfluentialSnakebite envenoming from a global perspective: Towards an integrated approach
Gutiérrez, J. M., Williams, D., Fan, H. W., & Warrell, D. A. (2010) · Toxicon · doi:10.1016/j.toxicon.2009.11.020 · Cited by 355
Research works printed but not linked: 5
- Scott D. L. Kini R. M. Phospholipase A2 structure and catalytic properties In Venom Phospholipase A2 Enzymes: Structure, Function, and Mechanism 1997 Chichester, UK John Wiley 97 128
- Mackessy S. P. Mackessy S. P. Snake Venom Phospholipase A2 Enzymes Handbook of Venoms and Toxins of Reptiles 2010 Boca Raton, Fla, USA Taylor and Francis 174 195
- Bon C. Kini R. M. Multicomponent neurotoxic phospholipases A2 Venom Phospholipase A2 Enzymes: Structure, Function, and Mechanism 1997 Chichester, UK John Wiley 269 285
- Mackessy S. P. Mackessy S. P. The field of reptile toxinology snakes, lizards, and their venoms In Handbook of Venoms and Toxins of Reptiles 2010 Boca Raton, Fla, USA Taylor and Francis 3 19
- Chen K. Zhong L.-P. Chen L.-Z. Li X. Xu X. Huang C.-H. Investigation and purification of snake venom secretory phospholipase A2 inhibitors from sera of some common snake species in Jiangxi province Pharmaceutical Biotechnology 2011 18 3 220 223 2-s2.0-79960816394
Cited by
Senji Laxme, R. R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007899 · Cited by 195
“While the mechanism of action of some of the snake venom toxins have been extensively studied [70, 79, 80], others, especially the least abundant toxins, remain chiefly underinvestigated.”
BackgroundCytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l -amino acid oxidase
Hiu, J. J., & Yap, M. K. K. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200110 · Cited by 149
Catalytically Active Snake Venom PLA 2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction
Castro-Amorim, J., de Oliveira, A. L. N., Silva, S. L. D., Soares, A. M., Mukherjee, A. K., Ramos, M. J., & Fernandes, P. A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00097 · Cited by 97
Lewin, M. R., Carter, R. W., Matteo, I. A., Samuel, S. P., Rao, S., Fry, B. G., & Bickler, P. E. (2022) · Toxins · doi:10.3390/toxins14110783 · Cited by 94
Hypotensive Snake Venom Components—A Mini-Review
Péterfi, O., Boda, F., Szabó, Z., Ferencz, E., & Bába, L.-I. (2019) · Molecules · doi:10.3390/molecules24152778 · Cited by 91
“Snake venom PLA2s are present in the venoms of species from the Colubridae, Elapidae and Viperidae snake families and they are one of the major toxic components with a wide spectrum of pharmacological effects [94].”
BackgroundExploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation
Wang, Y., Zhang, J., Zhang, D., Xiao, H., Xiong, S., & Huang, C. (2018) · Molecules · doi:10.3390/molecules23020391 · Cited by 87
“The reason was probably due to the lower PLA2 content in the two Elapid venoms [25].”
BackgroundSelf-citationSnake Antivenom: Challenges and Alternate Approaches
Alangode, A., Rajan, K., & Nair, B. G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114135 · Cited by 88
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
Bulfone, T. C., Samuel, S. P., Bickler, P. E., & Lewin, M. R. (2018) · Journal of Tropical Medicine · doi:10.1155/2018/4320175 · Cited by 83
Unraveling snake venom phospholipase A2: an overview of its structure, pharmacology, and inhibitors
Sampat, G. H., Hiremath, K., Dodakallanavar, J., Patil, V. S., Harish, D. R., Biradar, P. R., Mahadevamurthy, R. K., Barvaliya, M. J., & Roy, S. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00543-8 · Cited by 71
“Different venoms include various combinations of enzymes that have a more lethal impact than any one of them alone [12].”
BackgroundAnticancer Activity of Toxins from Bee and Snake Venom—An Overview on Ovarian Cancer
Moga, M., Dimienescu, O. G., Arvătescu, C. A., Ifteni, P. I., & Pleș, L. (2018) · Molecules · doi:10.3390/molecules23030692 · Cited by 70
“It is indispensable for various biological effects: cell growth and cell signaling, antiplatelet, anticoagulant, and hemolytic effects [68], as well as toxic effects such as neurotoxicity, cardiotoxicity, hypotensive, cytotoxicity, and proinflammatory [69,70].”
BackgroundPucca, M. B., Ahmadi, S., Cerni, F. A., Ledsgaard, L., Sørensen, C. V., McGeoghan, F. T. S., Stewart, T., Schoof, E., Lomonte, B., auf dem Keller, U., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00611 · Cited by 50
“Catalytically active svPLA2s hydrolyze membrane glycerophospholipids at the sn-2 site of these molecules (Xiao et al., 2017), however, many svPLA2s have over the course of evolution lost their catalytic activity, yet retain toxicity via other functions, such as an ability to disrupt cellular…”
BackgroundBjørn-Yoshimoto, W. E., Ramiro, I. B. L., Yandell, M. D., McIntosh, J. M., Olivera, B. M., Ellgaard, L., & Safavi-Hemami, H. (2020) · Biomedicines · doi:10.3390/biomedicines8080235 · Cited by 52
Estevão-Costa, M. I., Sanz‐Soler, R., Johanningmeier, B., & Eble, J. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.09.011 · Cited by 49
Chinnasamy, S., Selvaraj, G., Selvaraj, C., Kaushik, A. C., Kaliamurthi, S., Khan, A., Singh, S. K., & Wei, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.091 · Cited by 45
Carter, R. W., Gerardo, C. J., Samuel, S. P., Kumar, S., Kotehal, S. D., Mukherjee, P. P., Shirazi, F. M., Akpunonu, P. D., Bammigatti, C., Bhalla, A., et al. (2022) · Toxins · doi:10.3390/toxins15010022 · Cited by 39
“It is thought to be one of the components responsible for lethality from presynaptic neurotoxins and long-term morbidity such as that affecting return to work and activities of daily living [2,17].”
BackgroundNguyen, G. T. T., O'Brien, C., Wouters, Y., Seneci, L., Gallissà-Calzado, A., Campos-Pinto, I., Ahmadi, S., Laustsen, A. H., & Ljungars, A. (2022) · GigaScience · doi:10.1093/gigascience/giac121 · Cited by 43
“These results are in alignment with a high abundance of cytotoxins in the Naja genus and PLA 2 s in the Viperidae family, as well as a very low abundance of these 2 toxin families in the Dendroaspis genus.”
BackgroundInfluentialde Oliveira, A. L. N., Lacerda, M. T., Ramos, M. J., & Fernandes, P. A. (2024) · Toxins · doi:10.3390/toxins16020071 · Cited by 42
“Nevertheless, other usual effects caused by vvPLA2s include platelet aggregation, anti-coagulation, hemolysis, cytotoxicity, and neurotoxicity [21,22].”
BackgroundOffor, B. C., Muller, B., & Piater, L. A. (2022) · Toxins · doi:10.3390/toxins14110723 · Cited by 37
“Abbreviations: PLA2 = phospholipase A2; SVMPs = snake venom metalloproteinases; SVSPs = snake venom serine proteases; CRISP = cysteine-rich secretary protein; 3FTxs = three-finger toxins; CTL = C-type lectin; DIS = disintegrin; KUN = Kunitz-type peptides; LAAO = L-amino acid oxidase; CYS = cystatin (V = present and •…”
BackgroundInfluentialDingwoke, E. J., Adamude, F. A., Mohamed, G., Klein, A., Salihu, A., Abubakar, M. S., & Sallau, A. B. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101164 · Cited by 35
Conlon, J. M., Attoub, S., Musale, V., Leprince, J., Casewell, N. R., Sanz, L., & Calvete, J. J. (2020) · Toxicon X · doi:10.1016/j.toxcx.2020.100030 · Cited by 28
“…a variety of different phospholipids, J.M. Conlon et al. Toxicon: X 6 (2020) 100030 have been shown to exhibit antimicrobial, neurotoxic, myotoxic, anticoagulant, prostaglandin-mediated hypotensive, inflammatory, and antiangiogenic properties [reviewed in (Xiao et al., 2017; Trento et al., 2019)].”
BackgroundSnake Venom Components as Therapeutic Drugs in Ischemic Heart Disease
Messadi, E. (2023) · Biomolecules · doi:10.3390/biom13101539 · Cited by 27
Hempel, B.-F., Damm, M., Mrinalini, Göçmen, B., Karış, M., Nalbantsoy, A., Kini, R. M., & Süßmuth, R. D. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00869 · Cited by 26
Frihling, B. E. F., Boleti, A. P. D. A., de Oliveira, C. F. R., Sanches, S. C., Cardoso, P. H. D. O., Verbisck, N. V., Macedo, M. L. R., Rita, P. H. S., Carvalho, C. M. E., & Migliolo, L. (2022) · Pharmaceuticals · doi:10.3390/ph15060724 · Cited by 23
de Souza, C. L., dos Santos‐Pinto, J. R. A., Esteves, F. G., Pérez-Riverol, A., Fernandes, L. G. R., Zollner, R. D. L., & Palma, M. S. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.03.012 · Cited by 22
Xiao, H., Li, H., Zhang, D., Li, Y., Sun, S., & Huang, C. (2018) · Molecules · doi:10.3390/molecules23081911 · Cited by 21
“Thus, PLA2s are considered as promising ideal target for broad-spectrum anti-venom production [9].”
BackgroundSelf-citationWiezel, G. A., Bordon, K. D. C. F., da Silva, R. R., Gomes, M. S. R., Cabral, H., Rodrigues, V. D. M., Ueberheide, B. M., & Arantes, E. C. (2019) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-1470-18 · Cited by 23
Avella, I., Schulte, L., Hurka, S., Damm, M., Eichberg, J., Schiffmann, S., Henke, M., Timm, T., Lochnit, G., Hardes, K., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135041 · Cited by 20
Nusair, S. D., & Ahmad, M. I. (2019) · Toxicon · doi:10.1016/j.toxicon.2019.05.006 · Cited by 20
Borges, R. J., Marchi‐Salvador, D. P., Campanelli, H. B., Pimenta, D. C., Neto, M. D. O., Usón, I., & Fontes, M. R. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.083 · Cited by 18
Sandesha, V. D., Darshan, B., Tejas, C., Girish, K. S., & Kemparaju, K. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010292 · Cited by 18
Synthesis and diverse biological activities of substituted indole β-carbolines: a review
Zulkifli, S. Z., Pungot, N. H., Saaidin, A. S., Jani, N. A., & Mohammat, M. F. (2023) · Natural Product Research · doi:10.1080/14786419.2023.2261141 · Cited by 16
“The PLA 2 enzyme is also found in all groups of venomous snakes and is involved in the envenomation process (Xiao et al. 2017).”
Rodriguez, I. I. G., Francisco, Á. F., Moreira-Dill, L. S., Rueda, A. Q., Guimarães, C. L. S., Fernandes, C. A. H., Takeda, A. A. S., Zanchi, F. B., Caldeira, C. A. D. S., Pereira, P. S., et al. (2020) · Toxicon X · doi:10.1016/j.toxcx.2020.100049 · Cited by 16
Alves, Á. E. F., Barros, A. B. C., Silva, L. C. F. D., Carvalho, L. M. M., Pereira, G. M. A., Uchôa, A. F. C., Barbosa‐Filho, J. M., da Silva, M. S., Luna, K. P. D. O., Soares, K. S. R., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020204 · Cited by 16
“…venom serine proteases (SVSPs) that can cause coagulation inhibition; L-amino acid oxi-dases (LAAOs) causing cytotoxicity and oxidative stress; disintegrins (DISs) causing inhibition of platelet aggregation; and C-type lectins (CTLs) causing hemostasis modulation and blood coagulation [25,26].”
Damm, M., Avella, I., Merzara, R., Lucchini, N., Buldain, J., Corga, F., Bouazza, A., Soumia Fahd, D., Süßmuth, R. D., & Martínez‐Freiría, F. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.008 · Cited by 14
Simões‐Silva, R., Alfonso, J., Gómez, A., Sobrinho, J. C., Kayano, A. M., de Medeiros, D. S. S., Teles, C. B. G., Rueda, A. Q., Fuly, A. L., Gómez, C. V., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109581 · Cited by 14
Hoepner, C. M., Stewart, Z. K., Qiao, R., Fobert, E. K., Prentis, P. J., Colella, A. D., Chataway, T., da Silva, K. B., & Abbott, C. A. (2024) · Toxins · doi:10.3390/toxins16020085 · Cited by 14
Nielsen, V. G. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1763-6 · Cited by 13
Kiran, K. S., Kameshwar, V. H., Mudnakudu-Nagaraju, K. K., Nagalambika, P., Varadaraju, K. R., Karthik, N. A., Dugganaboyana, G. K., Swamy, S. N., Krishna, K. L., & Kumar, J. R. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116977 · Cited by 13
Schütter, N., Barreto, Y. C., Vardanyan, V. A., Hornig, S., Hyslop, S., Marangoni, S., Α, L. R.-S., Pongs, O., & Belo, C. A. D. (2019) · Toxins · doi:10.3390/toxins11060335 · Cited by 13
“Experiments with mouse hemidiaphragm preparations have shown that, like other neurotoxic PLA2s [15,16], MiDCA1 affects neurotransmitter release and the corresponding muscle twitch tension [13].”
BackgroundRedureau, D., Amorim, F. G., Crasset, T., Berger, I., Schaffitzel, C., Menzies, S. K., Casewell, N. R., & Quinton, L. (2025) · Toxins · doi:10.3390/toxins17050243 · Cited by 12
“%) and E. p. leakeyi (54.91%), exacerbate envenomation effects by stimulating platelet aggregation and causing anti-coagulation [55,56], contributing to bleeding disor-Toxins ders and thrombosis frequently reported during viper envenomation.”
InfluentialDingwoke, E. J. (2026) · Toxicon X · doi:10.1016/j.toxcx.2026.100246 · Cited by 12
“This approach defines toxin abundance, diversity, and modification patterns that contribute to clinical manifestations of envenoming (Calvete et al., 2009; Calvete, 2011, 2013; Lomonte and Calvete, 2017; Xiao et al., 2017).”
Campos, L. B., Pucca, M. B., Silva, L. C., Pessenda, G., Filardi, B. A., Cerni, F. A., de Oliveira, I. S., Laustsen, A. H., Arantes, E. C., & Barbosa, J. E. (2020) · Toxicon · doi:10.1016/j.toxicon.2020.05.027 · Cited by 10
Carbon monoxide inhibits the anticoagulant activity of Mojave rattlesnake venoms type A and B
Nielsen, V. G. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-01887-w · Cited by 10
Nielsen, V. G., Frank, N., & Turchioe, B. J. (2019) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000842 · Cited by 9
Bolon, B. N., Heinz-Taheny, K. M., Yeung, K. A., Oguni, J., Erickson, T. B., Chai, P. R., & Goldfine, C. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16153-7.00008-3 · Cited by 9
Costa–Leonardo, A. M., da Silva, I. B., Poiani, S. B., dos Santos‐Pinto, J. R. A., Esteves, F. G., da Silva, L. H. B., & Palma, M. S. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103622 · Cited by 9
Ojuka, P., Nyamato, G. S., Santos, C. B. R., & Kimani, N. M. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013579 · Cited by 8
“Its therapeutic potential as a natural venom inhibitor positions it as a key component in developing treatments for snakebite envenom-ations, particularly in cases involving cobras [156].”
Crous, C., Petzer, A., & Petzer, J. P. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14466 · Cited by 9
“…methyl treatment increased survival and significantly reduced the toxic effects of several different snake venoms (Bryan-Quiros et al., 2019; Gutiérrez et al., 2020; Lewin et al., 2016; Lewin, Gilliam, et al., 2018; Lewin, Gutiérrez, et al., 2018; Wang et al., 2018; Xiao et al., 2017, 2018).”
BackgroundWu, Y., Liao, G.-Y., Ke, H., & Liu, P. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s270443 · Cited by 10
Romero, L. E., Pulido, S., Berrío, M. A., Flórez, M. F., Rey-Suárez, P., Núñez, V., & Pereañez, J. A. (2022) · Toxins · doi:10.3390/toxins14120825 · Cited by 7
Herbs as Antidote for Snake Bite Treatment- Traditional Practices and Its Future Prospects- A Review
Raj, R. S. D. P., Mathew, A. A., Thathapudi, J. J., Beena Kanimozhi, R., & Preethy, H. A. (2022) · Journal of Natural Remedies · doi:10.18311/jnr/2022/28405 · Cited by 7
Rodrigues, C. F. B., Zdenek, C. N., Serino-Silva, C., de Morais-Zani, K., Grego, K. F., Bénard-Valle, M., Neri-Castro, É., Alagon, A. C., Tanaka-Azevedo, A. M., & Fry, B. G. (2021) · Journal of Chemical Ecology · doi:10.1007/s10886-021-01289-4 · Cited by 7
Avella, I., Schulte, L., Damm, M., Uhrig, L., Cabrera‐Orefice, A., Eichberg, J., Hardes, K., Hurka, S., Lindner, T., Vilcinskas, A., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013439 · Cited by 6
“…disrupt haemostasis [58], and that PLA 2 s are associated with a broad spectrum of biological activities, including cytotoxicity and coagulopathy [59,60], the high relative abundances of these two toxin families in our data is consistent with the clinical symptoms documented in cases of…”
Yusuf, A. J., Bugaje, A. I., Sadiq, M., Salihu, M., Adamu, H. W., & Abdulrahman, M. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.107838 · Cited by 6
Bothrops Moojeni Snake Venom: A Source of Potential Therapeutic Agents Against Hemostatic Disorders
Silva, N. B., Dias, E. H. V., Costa, J. D. O., & Mamede, C. C. N. (2024) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20220075 · Cited by 7
Snake Venom and 3D Microenvironment Cell Culture: From Production to Drug Development
Kato, E. E., Viala, V. L., & Sampaio, S. C. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2020009 · Cited by 5
“Neurotoxicity, Myotoxicity, Cytotoxicity, Cardiotoxicity, Hemolysis, Edema, Hyperalgesia Antiinflammatory Analgesic, Antitumoral, Antiangiogenic, Antibacterial, Antiviral [26,27]”
Bilateral Simultaneous Optic Neuritis Following Envenomations by Indian Cobra and Common Krait
Senthilkumaran, S., Miller, S., Williams, H. F., Thirumalaikolundusubramanian, P., Patel, K., & Vaiyapuri, S. (2022) · Toxins · doi:10.3390/toxins14110805 · Cited by 5
Razor: annotation of signal peptides from toxinsPreprint
Bhandari, B. K., Gardner, P. P., & Lim, C. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.30.405613 · Cited by 6
Clare, R. H., Westhorpe, A., Stars, E. L., Kazandjian, T. D., Albulescu, L.-O., Menzies, S. K., & Casewell, N. R. (2026) · eLife · doi:10.7554/elife.110419 · Cited by 5
Hatakeyama, D. M., Tasima, L. J., de Lima, E. O. V., da Silveira, G. P. M., Serino-Silva, C., Montemor, A. F., Tena-Garcés, J., Grego, K. F., Léo, P., & Tanaka-Azevedo, A. M. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108598 · Cited by 4
Reghu, N., Kiruthika, S., Santhosh, A. K., Narayanan, A. L., Geetha, K. G., Sidheek, N., Danthuluri, S. S., Nair, B. G., & Vanuopadath, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136000 · Cited by 4
“Because these toxins contribute not only to local inflammation and necrosis but also to anticoagulant, neurotoxic, and other systemic effects, PLA 2 s have become major therapeutic targets in snakebite research, with inhibitors such as varespladib showing promise as adjunct antidotes [121].”
Takayasu, B. S., Rodrigues, S. S., Trufen, C. E. M., Machado‐Santelli, G. M., & Onuki, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18317 · Cited by 4
Wiezel, G. A., de Oliveira, I. S., Ferreira, I. G., Bordon, K. D. C. F., & Arantes, E. C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135581 · Cited by 4
The secretory phenotypes of envenomed cells: Insights into venom cytotoxicity
Yong, Y., Hiu, J. J., & Yap, M. K. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.08.001 · Cited by 4
Small Molecule Therapeutics for the Initial and Adjunctive Treatment of SnakebitePreprint
Bulfone, T. C., Samuel, S. P., Bickler, P. L., & Lewin, M. R. (2018) · Preprints.org · doi:10.20944/preprints201804.0358.v1 · Cited by 4
Samianifard, M., Tahoori, F., Emami, T., Mirakabadi, A. Z., & Shirvan, A. N. (2023) · Archives of Razi Institute · doi:10.32592/ari.2024.79.1.154 · Cited by 3
Hull, J. A., Fusco, R. M., Tan, J., Ochoa, M. A., Hall, A., Wan, X., Loeb, E., & Asokan, A. (2025) · Journal of Virology · doi:10.1128/jvi.00799-25 · Cited by 3
Li, R., Cao, F., Chen, Y., Zhang, P., Huang, C., Xin, H., Wang, J., & Wang, X. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01388 · Cited by 3
Self-citationTrento, M. V. C., Carapiá, M. S., César, P. H. S., Braga, M. A., Soares, A. M., & Marcussi, S. (2021) · Acta Scientiarum Biological Sciences · doi:10.4025/actascibiolsci.v43i1.57016 · Cited by 3
Diniz, E. A. D. S., da Silva, D. P., Ferreira, S. D. S., Fernandes‐Pedrosa, M. D. F., & Vieira, D. S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2226912 · Cited by 3
“The focus on some specific targets such as PLA 2 aim to complement and enhance the effectiveness of serum therapy (Knudsen & Laustsen, 2018; Xiao et al., 2017).”
BackgroundCharacterization of plant produced VHH antibodies against cobra venom toxins for antivenom therapy
Vitayathikornnasak, S., Rattanapisit, K., Malla, A., Suwanchaikasem, P., Strasser, R., Khorattanakulchai, N., Pothisamutyothin, K., Arunmanee, W., & Phoolcharoen, W. (2024) · Biotechnology Reports · doi:10.1016/j.btre.2024.e00841 · Cited by 4
Diane Correia de Araújo, L. I. M. A., dos Santos, V. F., Rassi, B., Ward, R. J., & Soares, T. A. (2026) · Protein Science · doi:10.1002/pro.70449 · Cited by 2
“The key role of the i-face in snake venom sPLA 2 s interactions with target membranes has focused drug binding studies to this region (Xiao et al. 2017).”
Natural inhibitors of phospholipase A2: Current knowledge and therapeutic approaches
Leskovac, A. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95699-4.00015-3 · Cited by 2
Nanofractionation Analytics for Comparing MALDI-MS and ESI-MS Data of Viperidae Snake Venom Toxins
Xu, H., Mastenbroek, J., Krikke, N. T. B., El-Asal, S., Mutlaq, R., Casewell, N. R., Slagboom, J., & Kool, J. (2024) · Toxins · doi:10.3390/toxins16080370 · Cited by 2
“These lipid-hydrophilizing enzymes display a variety of pharmacological functions: acidic PLA 2 s inhibit platelet aggregation, whereas basic PLA 2 s are myotoxic, neurotoxic, and/or anticoagulant in nature [15].”
BackgroundYusuf, A. J., Ibrahim, N., Abdullahi, M. I., Adegboyega, A. E., & Salihu, M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402449 · Cited by 2
Megaly, A. M. A., Miyashita, M., Alqahtani, A. R., & Abdel-Wahab, M. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100566 · Cited by 2
The molecular basis of venom resistance in the non-venomous snake Sinonatrix annularis
Lian, Q., Zhang, D., Fu, K., Liu, C., Cao, L., Xiong, K., & Huang, C. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123182 · Cited by 2
Self-citationPereira, L. C. S., Amorim, N. D. M., de Oliveira, E. C., Sánchez, E. F., Ferreira, V. F., de Aquino, G. A. S., Ferreira, S. B., & Fuly, A. L. (2024) · Journal of Current Toxicology and Venomics · doi:10.2174/0126661217272344231208060944 · Cited by 1
Bide Your Time With Bites: A Case of Rattlesnake Envenomation in Pennsylvania
Zonna, X. C., Banta, C., Lott, R. G., Shah, S. S., Battista, A., & Colleran, C. (2024) · Cureus · doi:10.7759/cureus.66539 · Cited by 1
“…neuromuscular transmission in addition to causing myotoxicity through the disruption of cell membranes and calcium channels as well as coagulopathic effects through direct factor X inhibition and disrupted platelet aggregation resulting from the hydrolyzation of necessary phospholipids [9].”
BackgroundNeutralization of Naja naja venom by green and chemically synthesized titanium dioxide nanoparticles
Farrukh, F., Ahmed, S. M., Gul, A., & Waheed, H. (2025) · Nano Express · doi:10.1088/2632-959x/adb1fc · Cited by 1
Molecular docking analysis of bioactive molecules from herbs with snake venom phospholipase A2
Karthik Nagarajan., S., Annamalai, S., Christian, C. B. S. B., Rajamaheswari, K., Lavanya, A., & Arunachalam, K. (2025) · Bioinformation · doi:10.6026/973206300210290 · Cited by 1
Evolution and plasticity of snake venom: a systematic review
Siuli, R., Mishra, C. S. K., Muduli, L., & Pradhan, S. K. (2025) · The Nucleus · doi:10.1007/s13237-025-00577-8 · Cited by 1
Clare, R. H., Westhorpe, A., Stars, E. L., Kazandjian, T. D., Albulescu, L.-O., Menzies, S. K., & Casewell, N. R. (2026) · eLife · doi:10.7554/elife.110419.3 · Cited by 1
Shi, N., Wang, J., Xu, C., Jiang, X., Ren, C., Gao, X., & Luo, L. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00130 · Cited by 1
Itang, S. I., Navanita, S., Samanta, A., Kumar, M., & Sunagar, K. (2026) · Toxicon · doi:10.1016/j.toxicon.2026.109194 · Cited by 1
Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy
Laustsen, A. H. (2026) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70385 · Cited by 1
Phospholipases in inflammation, gene expression, and apoptosis
Padmanabhan, P., Prakash, D., Muralidar, S., Kamalakkannan, A., Gopal, G., & Ambi, S. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95698-7.00015-2 · Cited by 1
Pathological aspects of microbial phospholipases
Ghosh, R., Pal, S., Sarkar, S., & Dam, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21800-2.00017-8 · Cited by 1
Role of Plant-derived Bioactive Compounds in Potential Snakebite Envenoming: A Review
Mohanraj, S., Arthanari, S., Periyasamy, P., Chinnaiyan, S. K., Vijayan, N., Jambulingaeswaran, V., & Murugan, K. (2024) · Journal of Current Toxicology and Venomics · doi:10.2174/0126661217299051240722072656 · Cited by 1
Mitochondrial alterations induced by Macrovipera lebetina venom
Doltchinkova, V. R., Vitkova, V., Shkodrova, M., Kitanova, M., Lozanova, V. V., Lozanova, S. V., Ivanov, A. J., & Roumenin, C. S. (2025) · European Biophysics Journal · doi:10.1007/s00249-025-01796-2 · Cited by 1
“…tumors, leukemia), neurodegenerative diseases (e.g., Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis), and chronic conditions such as fatigue, pain, and aging (Casanova et al. 2023; Poulaki and Giannouli 2022; Pieńkowska et al. 2020; Fakhri et al. 2017; Xiao et al. 2017b).”
Dawood, M. M., Moonsamy, M. Z., Kokkas, K., Wang, H., Breiman, R. F., Klein, R., Sekyi, E. K., & Bassett, B. A. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2512.06502 · Cited by 1
Clare, R. H., Westhorpe, A., Stars, E. L., Kazandjian, T. D., Albulescu, L.-O., Menzies, S. K., & Casewell, N. R. (2026) · eLife · doi:10.7554/elife.110419.2 · Cited by 1
Alangode, A., Rajasekhar, A., Sabu, J. J., Krishna, S., Anuja, D., Sreeja, A., Remesh, G., Kaladevi, A., & Nair, B. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156830
“It hydrolyzes the phospholipids of the cell membrane at the sn-2 position of the glycerophospholipids, thereby releasing free fatty acids and lysophospholipids [9].”
(2018) · Journal of Pharmaceutical Research · doi:10.33140/jpr.03.02.03
“Snake venom causes considerable mortality and morbidity typically needing hospitalisation and sometimes causing enduring disabilities, and in severe cases may lead to death [1,2].”
BackgroundMoulasioti, V., Fotou, E., Moussis, V., Sgouras, D., & Tsikaris, V. (2022) · European Peptide Symposium (EPS) · doi:10.17952/36eps.2022.121
Snake venom phospholipases A2 and their roles in snakebite envenomings
Jiménez, J. A. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15313-6.00019-3
Madhu, M., Rao, A., & Puri, R. (2024) · PLANT ARCHIVES · doi:10.51470/plantarchives.2024.v24.no.1.008
“Thus, n-Hexadecanoic acid may serve as a superior candidate for anti-phospholipase A2 drugs showing promise as antidotes against a wide range of snake venoms and other animal toxins (Xiao et al ., 2017).”
BackgroundTurbal, L. V. (2024) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2024-28(2)-04
“That is why a more in-depth study of this problem can provide valuable information to representatives of the scientific field and practising medicine, which will improve the methods of treatment and prevention of poisoning by animal bites [21, 31, 33, 34].”
BackgroundAndrade-Silva, D. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-10042025-110422
Metadata
- Authors
- Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C.
- Affiliations
- Nanchang University (CN)
- Corresponding author
- Huang, Chunhong
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5727668
- OpenAlex
- W2773445094
- Cited by
- 113
- References
- 95
- Citations by year
- 2026: 19 · 2025: 16 · 2024: 16 · 2023: 13 · 2022: 15 · 2021: 5 · 2020: 10 · 2019: 11 · 2018: 8
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Natural Science Foundation of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Cultivating Foundation of Young Scientists of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
- Health Sciences › Medicine › Pharmacology (medical) › Healthcare and Venom Research
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
- Keywords
- snake venom phospholipase A2, snakebite, venomous snakes, Viperidae, Elapidae, Colubridae
- MeSH terms
- Animals, Antivenins, Drug Stability, Humans, Snake Venoms, Phospholipases A2, Phospholipase A2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.